Vaxcyte (PCVX) Cash from Financing Activities (2019 - 2026)
Vaxcyte's Cash from Financing Activities was -$5.33 million in Q3 2026, compared with -$3.67 million a year earlier.
Vaxcyte (PCVX) Cash from Financing Activities (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vaxcyte's Cash from Financing Activities was $604.37 million through Sep 30, 2026; for FY2025, it was $2.01 million, down 99.9% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of -64.8% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $2.45 billion in FY2024 (+282.7%), $639.81 million in FY2023 (-25.7%), $861.55 million in FY2022 and $17.8 million in FY2021 (-95.3%).
- The Q3 2026 figure marks the lowest quarterly Cash from Financing Activities in data going back to Q3 2019.
- Compared with a year earlier, Cash from Financing Activities was higher in two of the last five quarters, with an average decline of 8.5%.
- The best year-over-year quarter for Cash from Financing Activities over five years was Q2 2023 (growth of 996.6%); the worst was Q1 2025 (a decline of 99.9%).
- Per Business Quant data, PCVX's Cash from Financing Activities in the three quarters before Q3 2026 was $5.7 million (Q2 2026), $601.58 million (Q1 2026) and $2.41 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Vaxcyte | 9.91 Bn | 3.83 Bn | - | -5.33 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -5.33 Mn |
| Jun 30, 2026 | 5.70 Mn |
| Mar 31, 2026 | 601.58 Mn |
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 759,000.00 |
| Dec 31, 2024 | 4.91 Mn |
| Sep 30, 2024 | 1.52 Bn |
| Jun 30, 2024 | 110.37 Mn |
| Mar 31, 2024 | 818.20 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 48.55 Mn |
| Jun 30, 2023 | 546.97 Mn |
| Mar 31, 2023 | 41.56 Mn |
| Dec 31, 2022 | 656.63 Mn |
| Sep 30, 2022 | 44.02 Mn |
| Jun 30, 2022 | 49.88 Mn |
| Mar 31, 2022 | 111.02 Mn |
| Dec 31, 2021 | 8.75 Mn |
Vaxcyte Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PCVX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();